Australia markets open in 9 hours 7 minutes

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
27.50-0.13 (-0.47%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 5.58B
Enterprise value 4.73B
Trailing P/E 20.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.79
Price/book (mrq)2.47
Enterprise value/revenue 5.92
Enterprise value/EBITDA 16.35

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-37.35%
S&P500 52-week change 329.31%
52-week high 348.08
52-week low 323.07
50-day moving average 326.46
200-day moving average 333.43

Share statistics

Avg vol (3-month) 32.88M
Avg vol (10-day) 33.32M
Shares outstanding 5201.83M
Implied shares outstanding 6201.83M
Float 8112.91M
% held by insiders 143.18%
% held by institutions 118.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.44
Forward annual dividend yield 41.59%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.93
Payout ratio 432.12%
Dividend date 3N/A
Ex-dividend date 404 July 2023
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)27.29%

Management effectiveness

Return on assets (ttm)-11.59%
Return on equity (ttm)12.48%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA -505.18M
Net income avi to common (ttm)254.48M
Diluted EPS (ttm)1.37
Quarterly earnings growth (yoy)23.20%

Balance sheet

Total cash (mrq)1.62B
Total cash per share (mrq)8.18
Total debt (mrq)772.02M
Total debt/equity (mrq)34.17%
Current ratio (mrq)3.09
Book value per share (mrq)11.40

Cash flow statement

Operating cash flow (ttm)315.06M
Levered free cash flow (ttm)-746.46M